logo
Ndidi Okonkwo Nwuneli and Charlize Theron: Young Africans Are Ready to Lead. We Must Protect Their Health

Ndidi Okonkwo Nwuneli and Charlize Theron: Young Africans Are Ready to Lead. We Must Protect Their Health

If you want to glimpse the future, look to Africa—the youngest, fastest-growing continent brimming with potential. As two women raised in Africa, we've witnessed firsthand the incredible promise this continent holds.
By 2050, a quarter of people on Earth will be African. This youth boom is an unprecedented opportunity. With proper investments, these young people can drive innovation and economic growth globally. The next big tech disruptor? They could be coding in Lagos. The medical student ready to discover the next health innovation? They might be studying in Nairobi right now. They will found startups, staff entire industries, and supply the ingenuity every economic revolution needs.
There are already powerful stories emerging across Africa, showing what's possible when young Africans are given the opportunity and resources to thrive. In Nigeria, Temie Giwa-Tubosun founded LifeBank—the "Amazon for blood" —using technology to deliver blood and oxygen to hospitals, saving over 20,000 lives since 2016. From mobile money in Kenya to electric vehicles in Ghana, Africa's innovators are leading in fintech, green tech, and creative industries.
But right now, millions of young Africans risk never reaching their potential because of a disease we know how to prevent and treat.
Two decades ago, the world united against the AIDS crisis—and it worked. Twenty-six million lives have been saved, and 8 million babies were born HIV-free. Young people accessed life-saving medicine while maternal mortality declined. Africa's progress fighting HIV/AIDS has been revolutionary.
At the macro level, several African countries have achieved significant breakthroughs by setting the standard for inclusive growth. Take Botswana: once among the world's poorest nations with the highest HIV rates, Botswana's GDP per capita surged from just over $500 in 1966 to over $6,800 by 2018 – one of the fastest economic growth rates globally. In the same period, life expectancy rose from 54 to 66 despite the devastating effects of HIV. Botswana even exceeded targets for ending the HIV/AIDS epidemic four years early.
But this fight stands at a crossroads. Research published in the Lancet HIV last month warned that planned international aid cuts by the five largest donor countries could undo 25 years of progress at the stroke of a pen. In the worst case scenario, we could see 10.8 million additional HIV infections and 2.9 million more AIDS-related deaths by 2030—levels not seen since the early 2000s.
We're seeing the human cost of these funding cuts firsthand through our own work. In KwaZulu-Natal, for instance, where approximately 1.9 million South Africans live with HIV, 20-year-old performing arts student Dalisu relied on a PEPFAR-supported community-based program for youth-friendly healthcare. (Name has been changed to protect privacy.) As funding cuts forced that program to suddenly shut down, his only option for treatment is now his university clinic. Fear of stigma and discrimination has caused him to miss appointments, putting him at risk of viral rebound. Without urgent intervention, Dalisu's health and future hang in the balance. Millions of young Africans now face similar challenges as vital support programs evaporate.
Of course, being HIV-positive doesn't kill ambition. Many gifted people with access to treatment have built thriving careers. But imagine how many more success stories could emerge if fewer young people had to face this challenge in the first place. By continuing to tackle HIV at its root, we can unlock even greater potential, freeing individuals and communities from the burden it places on their health, education, and economies.
African leaders themselves are committed to a clear pathway to sustainability and fully financing their healthcare, with a focus on life-saving medicines and delivery mechanisms. Countries like Angola have transitioned from support for medical commodities, while others, like Nigeria and Ghana, are filling gaps left by aid cuts. There are also significant opportunities to join forces across the continent to invest in local manufacturing and joint procurement of medicines, thereby unlocking the economic opportunities in the health economy. Enhancing the efficiency, effectiveness, and accountability of treatment delivery, investing in health care workers and infrastructure, leveraging advances in technology, and engaging the diaspora to invest in the ecosystem will expedite this transition to full self-sufficiency.
Young Africans are ready to lead. They've shown what's possible when we invest in their health, education, and ideas. Now it's time for all of us—governments, philanthropists, and global citizens—to match that ambition. Our future depends on it.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

$9.7 million of U.S.-funded contraceptives for poor nations to be burned in France: Reuters
$9.7 million of U.S.-funded contraceptives for poor nations to be burned in France: Reuters

CNBC

time13 minutes ago

  • CNBC

$9.7 million of U.S.-funded contraceptives for poor nations to be burned in France: Reuters

U.S.-funded contraceptives worth nearly $10 million are being sent to France from Belgium to be incinerated, after Washington rejected offers from the United Nations and family planning organizations to buy or ship the supplies to poor nations, two sources told Reuters. A spokesperson for the U.S. State Department confirmed to Reuters on Wednesday that a decision had been taken to destroy the stock. The supplies have been stuck for months in a warehouse in Geel, a city in the Belgian province of Antwerp, following President Donald Trump's decision to freeze U.S. foreign aid in January. They comprise contraceptive implants and pills as well as intrauterine devices to help prevent unwanted pregnancies, according to seven sources and a screengrab shared by an eighth source confirming the planned destruction. The U.S. government will spend $167,000 to incinerate the stocks at a facility in France that handles medical waste, the U.S. State Department confirmed. The spokesperson said that a preliminary decision had been made to destroy certain products from terminated U.S. Agency for International Development contracts. "Only a limited number of commodities have been approved for disposal," the spokesperson said via email, adding that no condoms or HIV medications would be destroyed. U.S. lawmakers have introduced two bills this month to prevent the destruction of the supplies following Trump's decision to shut down USAID, but aid groups say the bills are unlikely to be passed in time to stop the incineration. The Belgian foreign ministry said Brussels had held talks with U.S. authorities and "explored all possible options to prevent the destruction, including temporary relocation." "Despite these efforts, and with full respect for our partners, no viable alternative could be secured. Nevertheless, Belgium continues to actively seek solutions to avoid this regrettable outcome," it said in a statement shared with Reuters on Tuesday. "Sexual and reproductive health must not be subject to ideological constraints," it added. The supplies, worth $9.7 million, are due to expire between April 2027 and September 2031, according to an internal document listing the warehouse stocks and verified by three sources. Sarah Shaw, Associate Director of Advocacy at MSI Reproductive Choices, told Reuters the non-profit organization had volunteered to pay for the supplies to be repackaged without USAID branding and shipped to countries in need, but the offer was declined by the U.S. government. "MSI offered to pay for repackaging, shipping and import duties but they were not open to that... We were told that the U.S. government would only sell the supplies at the full market value," said Shaw. She did not elaborate on how much the NGO was prepared to pay, but said she felt the rejection was based on the Trump's administration's more restrictive stance on abortion and family planning. "This is clearly not about saving money. It feels more like an ideological assault on reproductive rights, and one that is already harming women." She added that many countries in sub-Saharan Africa had relied on USAID for access to contraception and that the aid cuts would lead to a rise in unsafe abortions. The United Nations' sexual and reproductive health agency, UNFPA, also offered to buy the contraceptives outright, three sources told Reuters, without disclosing the financial terms of the proposal. However, negotiations broke down, a source with knowledge of the talks said, in part due to a lack of response from the U.S. government. UNFPA declined to comment. One of the sources with knowledge of the issue said that the Trump administration was acting in accordance with the Mexico City policy, an anti-abortion pact in which Trump reinstated U.S. participation in January. The pact forbids the U.S. government from contributing to or working with organizations providing funding or supplies that offer access to abortions. The source said there was no way for the U.S. government to ensure that UNFPA would not share the contraceptives with groups offering abortions, violating the Mexico City policy. The State Department also told Reuters these were factors in their decision on Wednesday, and added that it had avoided $34.1 million in costs by cancelling other orders placed under the Biden administration. The source also said the matter was complicated by the fact that the contraceptives in Belgium were embossed with the USAID trademark and Washington did not want any USAID-branded supplies to be rerouted elsewhere. UNFPA did not immediately respond to requests for comment on the concerns raised by the source. One of the two sources who told Reuters the stocks of contraceptives were being trucked to France said it would likely take dozens of truckloads and at least two weeks to move the supplies out of the Geel warehouse, with a third source also confirming the scale of the operation. The French government did not immediately respond to requests for comment. Chemonics, the contractor managing the supply chain for USAID's family planning program, declined to comment on the plans to destroy the supplies.

Gilead Sciences to Release Second Quarter 2025 Financial Results on Thursday, August 7, 2025
Gilead Sciences to Release Second Quarter 2025 Financial Results on Thursday, August 7, 2025

Yahoo

time41 minutes ago

  • Yahoo

Gilead Sciences to Release Second Quarter 2025 Financial Results on Thursday, August 7, 2025

FOSTER CITY, Calif., July 24, 2025--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its second quarter 2025 financial results and guidance will be released on Thursday, August 7, 2025 after the market closes. At 4:30 p.m. Eastern Time that day, Gilead's management will host a webcast to discuss the company's second quarter 2025 financial results and provide a business update. A live webcast will be available in the Investors section of and will be archived there for one year. About Gilead Sciences Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California. For more information on Gilead Sciences, please visit the company's website at follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000. View source version on Contacts Jacquie Ross, CFA – Investorsinvestor_relations@ Sign in to access your portfolio

Trump signs rescissions bill clawing back foreign aid, NPR and PBS funding
Trump signs rescissions bill clawing back foreign aid, NPR and PBS funding

CBS News

time41 minutes ago

  • CBS News

Trump signs rescissions bill clawing back foreign aid, NPR and PBS funding

Washington — President Trump signed legislation to claw back $9 billion in foreign aid and public broadcasting funding, the first time in decades that Congress has approved a president's request to rescind previously approved funding. White House spokesperson Harrison Fields said Thursday that the package was "officially signed." Both the Senate and House passed the legislation, known as a rescissions request, in overnight votes last week before a July 18 deadline. Each chamber ran into different hurdles in getting it over the finish line ahead of the deadline, after which the funds would have had to be spent as Congress originally intended. The bill targets roughly $8 billion for foreign assistance programs, including the United States Agency for International Development, or USAID. The package also includes about $1 billion in funding cuts for the Corporation for Public Broadcasting, which supports public radio and television stations, including NPR and PBS. Though all but two Republican senators ended up supporting final passage in the upper chamber, some said they had reservations about doing so, especially because they had not received details from the administration about how the broader cuts would impact specific programs. Two major points of contention were funding for a global AIDS prevention program and radio and broadcast stations in rural and tribal areas, which play a critical role in communicating emergency alerts and other information to residents. The final version of the package removed $400 million in cuts to the President's Emergency Plan for AIDS Relief, also known as PEPFAR, in an effort to appease some critics. The administration promised to find funding elsewhere to alleviate the cuts to the rural stations to win over others. Two House Republicans also opposed its passage in the lower chamber. Republicans said they expect it will be the first of multiple packages to claw back funding that they have characterized as "waste, fraud and abuse." Any future request is sure to spark another battle with lawmakers, some of whom have criticized the legislative body for giving up its budget oversight and ceding to the president's demands.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store